Heart & blood pressure · Wilmington, DE
Heart and blood pressure studies in Wilmington, DE
4 recruiting studies have a site in Wilmington.
4 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Amgen
- Location
- Wilmington, DE + 136 other US sites
- Eligibility basics
- Ages 45–99
- RecruitingPhase 2/Phase 3
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
Merck Sharp & Dohme LLC
- Location
- Wilmington, DE + 7 other US sites
- Eligibility basics
- Ages 6–17
- Recruiting
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Versono Medical Ltd
- Location
- Wilmington, DE + 5 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Wilmington, DE + 34 other US sites
- Eligibility basics
- Ages 12–18
Who these studies look for
Many require a diagnosis or specific lab values such as LDL cholesterol or blood pressure readings, and exclude recent heart events.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.